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Highly conserved proximal promoter element harbouring paired
Sox9-binding sites contributes to the tissue- and developmental
stage-specific activity of the matrilin-1 gene
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*Institute of Biochemistry, Biological Research Center of the Hungarian Academy of Sciences, Temesva´ri krt 62, H-6726 Szeged, Hungary, and †Agricultural Biotechnology Center,
Bioinformatics Group, P.O. Box 411, H-2101 Go¨do¨llo¨, Hungary
The matrilin-1 gene has the unique feature that it is expressed in
chondrocytes in a developmental stage-specific manner. Previ-
ously, we found that the chicken matrilin-1 long promoter with
or without the intronic enhancer and the short promoter with the
intronic enhancer restricted the transgene expression to the colum-
nar proliferative chondroblasts and prehypertrophic chondrocytes
of growth-plate cartilage in transgenic mice. To study whether
the short promoter shared by these transgenes harbours cartilage-
specific control elements, we generated transgenic mice expres-
sing the LacZ reporter gene under the control of the matrilin-1
promoter between −338 and +67. Histological analysis of the
founder embryos demonstrated relatively weak transgene activity
in the developing chondrocranium, axial and appendicular skele-
ton with highest level of expression in the columnar proliferating
chondroblasts and prehypertrophic chondrocytes. Computer ana-
lysis of the matrilin-1 genes of amniotes revealed a highly con-
served proximal Pe1 (promoter element 1) and two less-conserved
sequence blocks in the distal promoter region. The inverted Sox
motifs of the Pe1 element interacted with chondrogenic tran-
scription factors Sox9, L-Sox5 and Sox6 in vitro and another
factor bound to the spacer region. Point mutations in the Sox
motifs or in the spacer region interfered with or altered the form-
ation of nucleoprotein complexes in vitro and significantly de-
creased the reporter gene activity in transient expression assays
in chondrocytes. In vivo occupancy of the Sox motifs in genomic
footprinting in the expressing cell type, but not in fibroblasts, also
supported the involvement of Pe1 in the tissue-specific regulation
of the gene. Our results indicate that interaction of Pe1 with
distal DNA elements is required for the high level, cartilage- and
developmental stage-specific transgene expression.
Key words: cartilage-specific gene regulation, conserved pro-
moter element, in vivo footprinting, matrilin, Sox9-binding site,
transgenic mice.
INTRODUCTION
Vertebrate skeleton develops as a result of many morphogenetic
and differentiation steps [1]. Most skeletal elements are formed
by endochondral ossification through a cartilaginous template.
Chondrocyte precursors originate from the lateral plate meso-
derm, cranial neural crest and sclerotome. After migrating to
their destiny and undergoing commitment, the mesenchymal cells
first aggregate and form precartilaginous condensations in the
developing embryo. Then the prechondrocytes differentiate into
chondroblasts, which progress through several differentiation
stages including proliferation, maturation to chondrocytes and
hypertrophy. Finally, the mineralized hypertrophic cartilage is
replaced by bone. These differentiation steps are accompanied by
significant changes in the morphology and gene expression pattern
of the cells [1–3]. Thus the prechondrocytes and chondroblasts
turn off the mesenchymal marker genes and start to express the
cartilage protein genes in a sequential order [2–5]. In accordance
with the in vivo observations, activation of the genes for type II
collagen, aggrecan and cartilage link protein takes place in the
early proliferative stage (stage Ia), whereas the matrilin-1 gene
is turned on only in the late proliferative stage (stage Ib) of
in vitro chondrogenesis [2,6,7]. Recent advances shed light on
the transcriptional control of the chondrocyte lineage [8,9], but
our knowledge is still limited on the regulation of the sequential
activation of cartilage protein genes during chondrogenesis.
The essential role of three Sox proteins was reported in chon-
drogenic differentiation and in the activation of cartilage protein
genes [8,9]. Sox proteins carry a single HMG (high-mobility
group) box DNA-binding domain highly similar to that of Sry, a
mammalian testis-determining factor [10,11]. HMG box domains
interact with the minor groove of the DNA helix and bend the
DNA. They can also recognize four-way junction sequences [12].
Sox domains bind to the CA/TTTGA/TA/T motif with moderate
affinity [9,11,13]. In addition, some of the Sox proteins (e.g. Sox9)
have a transcription activation domain and thus work as typical
transcription factors. Furthermore, Sox proteins playing key roles
in development often interact with partner factors [11].
The Sox9, L-Sox5 and Sox6 genes are turned on in chondro-
progenitor cells and have a high level of expression in chon-
drocytes and some other cell types [8,9]. In campomelic dysplasia,
SOX9 haploinsufficiency leads to skeletal abnormalities and XY
sex reversal [14,15]. The absence of mesenchymal condensation
and endochondral bone formation as well as the lack of activ-
ation of cartilage protein genes in Sox9–/– transgenic mice iden-
tified Sox9 as a chondrogenic master transcription factor [16].
Double inactivation of L-Sox5 and Sox6 in transgenic mice also
severely interfered with chondroblast differentiation, prevented
the activation of the matrilin-1 gene and highly decreased the
expression level of genes for type II collagen (Col2a1), aggrecan
(Agc) and cartilage link protein (Crtl1) [17]. Furthermore, the
interaction of the 48 bp Col2a1 enhancer element with Sox9 and
Abbreviations used: CEC, chicken embryo chondrocyte; CEF, chicken embryo fibroblast; DMS, dimethyl sulphate; Dpe, distal promoter element; DTT,
dithiothreitol; EMSA, electrophoretic mobility-shift assay; GST, glutathione S-transferase; HDM, high-density mesenchyme; HMG, high-mobility group;
LM-PCR, ligation-mediated PCR; NFI, nuclear factor I; Pe1, promoter element 1; SI, silencer element I.
1 To whom correspondence should be addressed, at P.O. Box 521, H-6701 Szeged, Hungary (email kiss@nucleus.szbk.u-szeged.hu).
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L-Sox5/Sox6 in vitro indicated that Sox proteins could regulate
the Col2a1 transcription [18].
Previously, we cloned the gene for chicken matrilin-1 [19], the
first member of the matrilin family of multiadhesion proteins.
Matrilins are expressed in a unique and partially overlapping
pattern and function as oligomeric adaptor molecules in the extra-
cellular matrix of skeletal and other tissues [20]. Matrilin-1
(previously called cartilage matrix protein, CMP) is highly abun-
dant in certain forms of hyaline cartilage. It can covalently bind to
aggrecan [21] and, through the vWFA domains, it can form both
collagen-dependent and independent fibrillar extracellular net-
works [22]. Thus matrilin-1 may perform a bridging function
between the two major macromolecular networks of cartilage.
The matrilin-1 gene also serves as a marker gene for the late pro-
liferative stage of chondrogenesis [6,7].
The major control regions of the chicken matrilin-1 gene were
mapped previously [23–25]. In transient expression experiments,
we found a chondrocyte-specific positive control region in the first
intron [23]. We also showed that the promoter fragment between
positions −1137 and +64 conferred tissue- and developmental
stage-specific regulation to the reporter gene due to an interplay
between two positive and two negative regions [24]. We char-
acterized the TATA proximal SI (silencer element I), which func-
tioned by binding NFI (nuclear factor I)-family proteins. Recently,
we have also provided evidence in transgenic mice that the long
promoter (between−2011 and+67) alone and the short promoter
with the intronic fragment (between −338 and +1819) were
equally capable of directing the differentiation stage-specific ex-
pression of the reporter gene in chondrocytes [25]. In congruence
with the expression pattern of the endogenous matrilin-1 gene, ac-
tivity of the transgenes was restricted to the columnar proliferating
and prehypertrophic zones of the growth plate. However, the
presence of both promoter upstream and intronic elements was
necessary for the high-level transgene activity in all chondrogenic
tissues and for the extraskeletal transgene expression pattern
closely resembling the chicken matrilin-1 gene [25]. Our results
suggested that relatively weak cartilage-specific elements dis-
persed in the promoter and first intron regulate the chicken gene.
To gain further insight into the transcriptional control of the
restricted tissue-specific expression of the matrilin-1 gene, we
searched for conserved motifs in the promoters of various verte-
brate species and addressed the question whether Sox proteins
are involved in this regulation. In the present study, we report on
the functional analysis of the chicken matrilin-1 short promoter
in transgenic mice and identification of a highly conserved DNA
element interacting with cartilage-specific Sox factors in vitro.
In vivo occupancy of the identified factor-binding sites is also
studied in genomic footprinting, and the putative role of the
element in the transcriptional control of the gene is discussed.
EXPERIMENTAL
Sequence analysis
All sequences were obtained either from the ENSEMBL genome
browser [26], or from the EMBL databank [27]. Sequence mani-
pulations were performed using the programs of the EMBOSS
package [28]. Multiple alignments were made by the DIALIGN2
program [29] and were further improved by hand. Conserved
motifs were searched with the MEME motif discovery program
[30].
Oligonucleotides and plasmid constructions
Double-stranded oligonucleotides were synthesized for Pe1 (pro-
moter element 1): 5′-TCTCCGAGCAATGGAGCCATTGTGG-
AGGGG-3′; the consensus HMG box site: 5′-ACACTGAGA-
ACAAAGCGCTCTCACAC-3′; and the consensus Sox element:
5′-GATCCGGACTAATAAACAATAAAGTCGACG-3′. Nucle-
otide sequences for the point mutant versions of Pe1 referred to as
Pe1M1, Pe1M2, Pe1M3 and Pe1M4 are depicted in Figure 7(A).
As reported in [23], all positions are given in bp from the first
T of the TATA motif of the chicken matrilin-1 gene. Plasmid
pJB-AD was made by ligating the NotI, SalI, PstI, HindIII, BglII
and NcoI polylinker at the NotI and NcoI sites of vector pJB-HRV
[25] upstream of the LacZ cassette bordered by a nuclear transport
signal and the MP1 polyadenylation site. To construct NAD1,
the KpnI (blunted)–NcoI fragment from a subclone carrying the
matrilin-1 short promoter between −334 and +67 was inserted
at the HindIII (blunted) and NcoI sites of pJB-AD.
The AvaI (blunted)–NcoI fragment harbouring the matrilin-1
minimal promoter between positions −15 to +67 was inserted
into the SmaI and NcoI site of the pGL3-basic vector (Promega,
Madison, WI, U.S.A.) to produce MpLuc. In construct 4×Pe1-
MpLuc, four copies of the Pe1 element subcloned in the EcoRV
site of pBluescript II SK(+) (Stratagene, La Jolla, CA, U.S.A.)
was excised with SacI–HindIII (blunted) and ligated to the SacI–
NheI (blunted) site of MpLuc. The SacI–NcoI fragment including
the proximal promoter region of chicken matrilin-1 gene between
−334 and +67 was ligated to the SacI and NcoI site of the
pGL3-basic vector to produce the FO15Luc construct. FO15Luc
derivatives∆Pe1M1 and∆Pe1M4 were made by PCR-based Quik
Change® site-directed mutagenesis (Stratagene) according to the
manufacturer’s instructions using FO15Luc as a template and
oligonucleotides Pe1M1 and Pe1M4 carrying point mutations
in the Sox9 recognition site and in the spacer region of Pe1
respectively. Two synthetic oligonucleotide primers containing
the desired mutation, each complementary to opposite strands
of the vector, were extended during temperature cycling by
Pyrococcus furiosus DNA polymerase (Fermentas AB, Vilnius,
Lithuania). After the cycling, the products were treated with
DpnI digestion to eliminate the methylated parental template. The
nicked DNAs were then transformed into Escherichia coli and
repaired. The BglII–NcoI matrilin-1 promoter fragment between
−1137 and +67 was inserted into the BglII and NcoI sites of
pGL3-basic to obtain pCMPLuc. AC8Luc carries the long PstI
(blunted)–NcoI promoter fragment between positions−2011 and
+67 at the SmaI (blunted) and NcoI sites of the same vector. The
structure of all the constructs and the accuracy of the mutagenesis
were verified by restriction mapping and nucleotide sequencing.
Generation and analysis of transgenic mice
To generate transgenic mice, the purified NotI–XhoI fragment
of NAD1 was microinjected into the male pronuclei of fertilized
oocytes obtained from (C57BL/6×CBA)F1 intercrosses as des-
cribed in [25]. Recipient females were killed on E15.5 (embryonic
day 15.5), and the presence of the transgene in founder (G0)
embryos was detected by PCR analysis and dot-blot hybridization
of placental DNA. Positive G0 embryos were fixed and stained
with X-Gal, photographed as whole mounts, and subjected for
histological analysis as described previously [25]. All animal
experiments were conducted according to the ethical standards of
the Animal Health Care and Control Institute, Csongra´d County,
Hungary.
Cell culture
Preparation of CEC (chicken embryo chondrocyte) and CEF
(chicken embryo fibroblast) cultures and HDM (high-density mes-
enchyme) cultures undergoing chondrogenesis in vitro was de-
scribed in [6,24]. The mouse fibroblast cell line NIH3T3 was
c© 2005 Biochemical Society
Conserved promoter element of the matrilin-1 gene 3
Figure 1 Diagram of the promoter region of the chicken matrilin-1 gene analysed using in vivo and in vitro techniques
(A) Schematic figure of the 5′-end of the gene depicts the location of conserved sequence blocks harbouring potential distal (Dpe1 and Dpe2) and proximal promoter elements (Pe1) and initiator
element (Ine). Numbers indicate the positions relative to the TATA motif. In the expanded view of the proximal promoter region, horizontal arrows mark the location of primers used in genomic
footprinting and oval symbols denote the SI and SII elements. Inverted arrows represent the inverted pairs of conserved Sox9 and L-Sox5/Sox6 motifs in Pe1 and Dpe1 respectively. Closed circle
and closed triangles depict the putative Ikaros2- and EF-binding sites in a potential neural crest-specific element (Nce) discussed previously [25]. (B) Schematic map of the vector pJB-AD and
the fusion construct NAD1 carrying the short promoter of the chicken matrilin-1 gene, the LacZ cassette preceded by the SV40 nuclear transport signal (nts) and the MP-1 polyadenylation signal.
obtained from A.T.C.C. (Manassas, VA, U.S.A.) and maintained
in Dulbecco’s modified Eagle’s medium and 10 % (v/v) fetal calf
serum (Sigma–Aldrich, MO, U.S.A.).
In vivo footprinting with DMS (dimethyl sulphate) and UV light
A total of 7.5× 106–1× 107 CEC and 5× 106 CEF cells were
treated with 0.2% DMS for 5 min at room temperature (22 ◦C)
or irradiated with 2400 J/m2 UV light in vivo and subjected to
genomic footprinting as described in [31]. Briefly, genomic DNA
was isolated from the cultures treated in vivo (v) by incubation
with 600 µg/ml proteinase K and compared with ‘naked’ DNA
treated with DMS and UV light in vitro (t). DNA samples (30 µg
of ‘v’ and ‘t’) were cleaved with 100 µl of 1 M piperidine at 88 ◦C
for 30 min and amplified by LM-PCR (ligation-mediated PCR)
[31] between positions −227 and +140 using gene-specific nes-
ted primers PU1, 5′-TGTTCCCATCCCAGATTCC-3′ and PU2,
5′-TCCCAGATTCCCCACATACCGC-3′ for the upper strand;
PL1, 5′-GGAGGTGCCCCCCAGA-3′ and PL2, 5′-TGCCCCCC-
AGACTCCACAGCT-3′ for the lower strand (Figure 1A); and
linker primers LP11, 5′-GAATTCAGATC-3′ and LP25, 5′-GCG-
GTGACCCGGGAGATCTGAATTC-3′. First, a gene-specific
primer (PU1 or PL1) annealed to the cleaved and denatured
genomic DNA was extended with SequenaseTM and the double-
stranded linker was blunt-end ligated. Then the fragments were
PCR-amplified using LP25 and PU2 or PL2. The PCR ladders
were separated on sequencing gels with G+A and C+T se-
quence ladders, transferred on to nylon membranes and hybridized
with 32P-labelled single-stranded PCR probes made with gene-
specific primers PU3, 5′-GCGTGGCTGCGGGTCCCT-3′ or PL3,
5′-CCACAGCTCTGGAGGAGAAGCAG-3′ (Figure 1A).
Preparation of cell extracts
Crude cell extracts were made from CEC, CEF and NIH3T3 cul-
tures for EMSA (electrophoretic mobility-shift assay). Cells were
lysed in 20 mM Hepes (pH 7.9), 350 mM NaCl, 0.5 mM EDTA,
0.5 mM EGTA, 2 mM DTT (dithiothreitol), 0.2 mM PMSF and
1% Nonidet P 40 on ice for 30 min. The chromatin was centri-
fuged for 5 min at 20800 g at 4 ◦C. The supernatants were supple-
mented with 10% (v/v) glycerol, aliquoted and stored at−80 ◦C.
Synthesis and purification of bacterially expressed GST
(glutathione S-transferase)–SOX9
The GST–SOX9 vector for bacterial expression of the fusion of
GST with full-length SOX9 and the empty control vector were
kindly provided by P. Berta (University of Freiburg, Freiburg,
Germany; [32]). The recombinant protein was produced in
bacterial strain BL21-CodonPlus (DE3)-RIL after induction with
0.1 mM isopropyl-β-D-thiogalactopyranoside for 2 h at 37 ◦C.
The cells were harvested, resuspended in 150 mM NaCl, 1 mM
DTT, 5 mM EDTA, 25% (w/v) sucrose and 50 mM Tris (pH 7.5),
and sonicated for 2 min at 4 ◦C. After centrifugation, the cleared
lysate was applied on to glutathione-SepharoseTM 4B beads
(Amersham Biosciences, Upsala, Sweden) and washed three
times in 250 mM NaCl, 5 mM EDTA, 50 mM Tris (pH 7.6) and
three times in 120 mM NaCl, 5 mM EDTA and 50 mM Tris
(pH 7.6). Purified proteins were eluted from the matrix with the
latter buffer supplemented with 10 mM GSH by incubating for
30 min at 4 ◦C. Yields were tested by SDS/PAGE.
EMSA and supershift experiments
Crude cell extracts were incubated in the presence of 100 ng of
poly(dG-dC) · (dG-dC) and various unlabelled competitors with
c© 2005 Biochemical Society
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Figure 2 Conserved sequence blocks in the matrilin-l promoter region of amniotes
In the alignment made by the DIALIGN2 program [29], the most conserved regions between the human, mouse, rat, dog and chicken matrilin-1 promoter sequences are shown. The human, mouse
and rat matrilin-1 promoter sequence data are from the ENSEMBL database [26], the dog sequence is from the EMBL database (accession no. AACN010934065). Positions are given relative to
the TATA box. Asterisks mark the fully conserved nucleotides. Interrupted horizontal arrows above and below the consensus sequence of Dpe1 and Pe1 indicate putative Sox motifs marking those
nucleotides that are identical with the consensus L-Sox5/Sox6 and Sox9 recognition sequences respectively shown in a separate box.
10–20 fmol of end-labelled DNA probe, and loaded on prerun
5–6.6% polyacrylamide gel in 22.5 mM Tris/borate/0.25 mM
EDTA (pH 8) as described in [24]. Supershift experiments were
performed as described in [24] with antisera raised against SOX9,
L-Sox5 and Sox6 [18] kindly provided by B. de Crombrugghe and
V. Lefebvre (University of Texas, M.D. Anderson Cancer Center,
Houston, TX, U.S.A.).
Transient expression assay
CEC, CEF and HDM cultures were transfected with the calcium
phosphate co-precipitation method as described in [24]. Cells
were transfected 24 h after plating with 5 µg of each luciferase
construct. To test for transfection efficiency, 0.5 µg of pCAT®3
control vector (Promega) was included as an internal control, and
an empty vector was added to have a total DNA amount of 10 µg.
Parallel plates were also transfected with pGL3-control vector
(Promega). The transfected cells were harvested 48 h later by
centrifugation and the cell pellet was lysed by two cycles of
freezing and thawing in 200 µl of 50 mM Tris/HCl, 2 mM
DTT, 0.5 mM EDTA, 0.5 mM EGTA and 1% Nonidet P40.
Luciferase activity was measured from the supernatant in a Lumi-
noscan Ascent (ThermoLabsystem 2.6) using luciferin substrate
(Promega) [33]. Relative luciferase activities were expressed in
percentage of that of FO15Luc taken as 100%. All transfections
were performed in duplicates with at least two different DNA
preparations. Data are presented as means+− S.E.M.
RESULTS
Identification of conserved sequence blocks in the promoters
of amniote matrilin-1 genes
To identify potential control elements in the regulatory region of
the matrilin-1 gene, we searched for conserved sequence blocks
in various vertebrate species using the DIALIGN2 program [29].
The location of the most-conserved DNA segments is shown
in Figure 1(A). Within the 2–3 kb promoter region tested, only
one putative element exhibited very strong sequence conservation
between mammals and chicken. This proximal promoter element,
herein referred to as Pe1, is located 100–200 bp upstream of
TATA in amniotes and includes a pair of inverted motifs highly
similar to the AGAACAATGG motif, which was shown to be
the preferred binding site of Sox9 in vitro [13] (Figure 2). The
inverted Sox motifs are separated by two nucleotides within Pe1.
Apart from this, only two distal DNA segments [Dpe1 (distal
promoter element 1) and Dpe2] show a certain degree of sequence
similarity between mammals and chicken (Figures 1A and 2).
Dpe1 harbours motifs sharing 6/8 bp identity with the preferred
recognition sequence for L-Sox5/Sox6 [13]. Dpe2 includes
the fully conserved GACACAGAGAA motif, which does not
match with any consensus motif of known transcription factors
of the TRANSFAC® database (http://www.gene-regulation.com/
pub/databases.htm1#transfac). The degree of sequence similarity
around the TATA motif was relatively weak when compared with
other eukaryotic promoters. Apart from the TATA box, only the
c© 2005 Biochemical Society
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Figure 3 Transgene expression pattern in NAD1 embryos
COLOUR
Transgenic founder mice carrying the NAD1 transgene were killed at E15.5. Whole-mount X-Gal staining reveals relatively weak and diffuse LacZ expression in the developing chondrocranium, axial
and appendicular skeleton. KFE, ‘sacrificed’ (killed) founder embryos. Scale bar, 2 mm.
TGTGCCG/A motif was found uniformly in the initiator element
(Ine) of various amniote species tested (Figure 2). This motif
harbours the first transcription start site of the chicken gene.
Functional analysis of the short matrilin-1 promoter
in transgenic mice
The TR70, VAM1 and VAM2 transgenes exhibiting zonal expres-
sion in the growth plate [25] shared the short matrilin-1 promoter.
To study whether the short promoter harbouring the conserved Pe1
element can significantly contribute alone to the transcriptional
regulation of the gene, we fused the chicken matrilin-1 promoter
between –334 and +67 to the LacZ reporter gene. The fusion
construct NAD1 (Figure 1B) was microinjected into the pronuclei
of fertilized mouse eggs, and the founder embryos were killed at
E15.5 to study the β-galactosidase activity by whole mount X-
Gal staining (Figure 3) and histological techniques (Figure 4).
Altogether 12 positive founder embryos expressing the transgene
at detectable level by histology were analysed in detail. Each of
these embryos exhibited LacZ expression of a similar pattern in
all the developing cartilaginous elements of the chondrocranium,
appendicular and axial skeleton (Figures 3 and 4). The level of
LacZ expression was somewhat weaker than that in the killed
VAM2 embryos carrying intronic sequences in addition to the
same short promoter as harboured by NAD1 [25]. X-Gal staining
showed zonal differences in the transgene expression pattern in
the cartilage growth plates of developing long bones and verte-
bral bodies (Figure 4), albeit the zonal differences were less pro-
nounced than it was demonstrated for the TR70 and VAM2
transgenes carrying longer promoter and intronic regions respec-
tively [25]. In agreement with the expression pattern of the endo-
genous matrilin-1 gene, the level of NAD1 transgene expression
was generally highest in the columnar proliferating chondroblasts
and prehypertrophic chondrocytes, whereas a lower level of ex-
pression was seen in the zones of epiphyseal and resting
(also called source [34]) chondroblasts and upper hypertrophic
chondrocytes (panels A–F). The site of integration only slightly
influenced the level and pattern of expression in cartilage. Similar
to previous observations [25], not all cells exhibited LacZ activity
even in the zones of expression (panels D, E, I and Q). Differing
from the TR70, VAM1 and VAM2 transgenes, however, no
decrease was observed in the β-galactosidase activity in proximal
as compared with distal structures during the progression of endo-
chondral bone formation. For example, the NAD1 transgene
activity in the cranial vertebral bodies was comparable with that in
the caudal vertebral bodies of the same embryo (compare panels
G and H). This suggests that the short promoter lacks control ele-
ments repressing the transgene expression in proximal structures.
X-Gal staining of similar intensity was also observed in the
inner annulus chondroblasts and nucleus pulposus of interve-
rtebral discs, in the eye and collecting tubules of the developing
kidney in most of the NAD1 transgenic embryos (panels G, M–P;
and results not shown). Apart from this, ectopic LacZ expression
of very faint to moderate intensity and of variable pattern was
noticed in other tissues of some of the embryos, such as in
osteoblasts, olfactory epithelium and semicircular canals of inner
ear (panels D, Q and R). Occasionally, staining was also seen in
skeletal muscle, heart muscle or lung of certain embryos, or in cer-
tain elements of the central and peripheral nervous system (panels
K, L; and results not shown). The variable ectopic expres-
sion pattern in non-chondrogenic tissues rather suggests the in-
fluence of the integration site than the intrinsic activity of the pro-
moter elements.
From these results, we conclude that the short promoter
harbours a cartilage-specific control element, which is preferably
active in certain developmental stages and in distinct zones of the
growth plate. However, it is not 〈#〉 to direct a high-level transgene T1
activity fully restricted to certain chondrocyte differentiation
stages and completely independent of the site of integration.
Cartilage-specific occupancy of the conserved Pe1 element by
nuclear proteins in vivo
To detect whether transcription factors are bound to the putative
recognition sequences within the proximal promoter region
in vivo, we used the sensitive genomic footprinting strategy in
combination with LM-PCR [31]. A series of primers was designed
to cover 360 bp around the TATA motif (Figure 1A). The matrilin-
1 expressing CEC cultures in comparison with the non-expressing
CEF cultures were subjected to in vivo analysis. Genomic DNA
was treated with DMS or UV light to modify G residues at
N-7 position or produce (6–4) photoproducts at TC and CC
dinucleotides respectively. These modifications are sensitive to
bound proteins, therefore the areas of protein–DNA interactions
appear as footprints on LM-PCR genomic sequencing ladders
[31]. LM-PCR analysis of naked CEC and CEF DNA treated
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Figure 4 Histological analysis of the NAD1 transgene expression
COLOUR
Sagittal cryosections were made from E15.5 killed founder embryos (KFE, ‘sacrificed’ founder embryos) whole-mount stained with X-Gal. The sections were counterstained with eosin. LacZ expression
is seen in the developing metatarsals (mt) (A, B), tibia (ti) and fibula (fi) (C), femur (D) of the hind limbs, humerus (E) and iliac bone (F). The intensity of X-Gal staining is relatively the highest
in the zones of columnar proliferating chondroblasts (pro) and prehypertrophic chondrocytes (ph), and weaker in the epiphyseal chondroblasts (epi), resting (res) and hypertrophic (hyp) zones of
growth plate cartilage (A–F, J). X-Gal staining is visible in the proliferating chondroblasts and prehypertrophic chondrocytes of cranial (G), lumbal (M) and caudal (H, N, O) vertebral bodies (vb),
in the inner annulus (ia) and nucleus pulposus (np) of developing intervertebral discs (G, M–O). The level of LacZ expression is similar in the proliferating chondroblasts of cranial (G) and caudal
(H) vertebral bodies within the same embryo. Expression can also be seen in the cartilaginous primordia of Meckel’s cartilage (m) (I), temporal (t) (Q) and nasal bones (nb; R), in the longitudinal
c© 2005 Biochemical Society
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Figure 5 Cartilage-specific occupancy of the Pe1 and SII elements in
genomic footprinting
(A) Footprints are shown between positions –169 and –125 on the lower strand of the DNA.
AG and CT are Maxam–Gilbert control sequences. DNA from CEC and CEF cultures treated
in vivo (v) with DMS (open and closed boxes) or UV light (open and closed circles) is compared
with the in vitro (t) DNA samples treated with these reagents after isolation from CEC and CEF.
Differences in themodification patterns between ‘v’ and ‘t’ treatments, visible as hyper-reactivities
(large and small closed circles or closed boxes) or protections (large and small open circles or
open boxes), indicate in vivo DNA–protein contacts at specific sequences. (B) Summary of the
in vivo footprinting data is shown on both strands. The previously identified NFI-binding site
in the SII element and the inverted repeat harbouring the putative paired Sox-binding sites are
boxed.
with the same reagents in vitro served as a reference. Differences
in the modification patterns between the in vivo and in vitro
treated samples, apparent as hyporeactivities (protections) or
hyperreactivities, indicated in vivo DNA–protein contacts at
specific sequences.
Sets of independent experiments revealed cartilage-specific
binding of transcription factors to the short promoter (Figure 5).
We focused on the region where sequence conservation during
evolution was obvious, that is on the vicinity of the Pe1 element
between –169 and –125. Results of DMS and UV footprinting
obtained on the upper and lower strands of DNA (Figure 5A; and
results not shown) are summarized in Figure 5(B). Apart from Pe1,
the first region also covered the SII element identified previously
[24]. In chondrocytes, occupancy was observed at the NFI contact
points of the SII element (Figure 5A, lanes 1, 2, 5 and 6). The
conserved Pe1 between –169 and –139 was also clearly protected
by bound transcription factors at certain G, CC and CT nucleotides
of the inverted Sox motifs, whereas hypersensitivity was seen on
the opposite strand. Furthermore, hyporeactivity indicated factor
binding at G residues of an Sp1-like motif between the Pe1 and
SII elements (Figure 5) and also at G residues of several Sp1-like
elements located between SII and the TATA motif (results not
shown). These results demonstrate in vivo occupancy of potential
recognition sequences for Sox9 and certain ubiquitous factors as
well within Pe1 and its vicinity in chondrocytes (Figure 5B). As
opposed to this, the complete absence of footprints in the short
promoter in fibroblasts in repeated experiments indicated no
factors bound to their recognition sequences in the non-expressing
cell type (Figure 5A, lanes 3, 4, 7 and 8, Figure 5B; and results
not shown). This suggests that regulation at the chromatin level
can be involved in the activation of the gene in chondrocytes.
Sox9, L-Sox5 and Sox6 interact with the Pe1 element in vitro
The inverted repeats within the conserved Pe1 element, which
exhibited cartilage-specific protection in genomic footprinting,
share 7/10 bp identity with the consensus Sox9-binding site
(Figure 2). To confirm that Sox9 can indeed bind to Pe1 in the
DNA-binding assay in vitro, bacterially expressed and purified
GST–SOX9 fusion protein was incubated with the element. As
demonstrated in Figure 6(A), the recombinant SOX9 formed a
nucleoprotein complex efficiently on the element (lanes 3–6).
When EMSA was performed with nuclear proteins from CEC,
NIH3T3 and CEF cultures, we noticed tissue-specific differences
in the pattern and behaviour of complexes (Figure 6B, lanes 1–4).
Two specific DNA–protein complexes absent from fibroblasts
were formed with CEC nuclear proteins (lane 2). Competition
EMSA revealed that double-stranded oligonucleotides harbouring
consensus Sox or HMG box motifs interfered only with the for-
mation of the slowly migrating complex II (lanes 8–11). The
same complex was supershifted with antibodies specifically reco-
gnizing Sox9, L-Sox5 and Sox6 (Figure 6C), indicating that each
of the cartilage-specific Sox transcription factors participated in
the formation of complex II on Pe1 in chondrocytes. On the
other hand, the observation that complex I was neither competed
nor supershifted with Sox-specific oligonucleotides or antibodies
respectively, indicated that the element also interacted with other
transcription factors in the expressing cell type. Together, these
results provide sufficient evidence to conclude that the chon-
drocyte-specific in vivo footprints at the inverted Sox motifs of Pe1
might be due to the binding of Sox9, L-Sox5 and Sox6 proteins.
In addition, the Pe1 element can also form a complex with an
unrelated chondrocyte nuclear protein.
Mutations in either of the paired Sox motifs of Pe1 interfere
with protein binding in EMSA
To examine further the Pe1 element, point mutations were intro-
duced into either one (Pe1M1 and Pe1M2) or both (Pe1M3) of
(K) and cross (L) sections of the developing ribs (r) and in the eye (P). Ectopic expression is occasionally observed in non-chondrogenic tissues, e.g. the olfactory epithelium (oe) (R), epithelial
cells of the semicircular canals (sc) of inner ear (Q), in the intervertebral (im) and cutaneous muscles (cm) (K, L) and in the osteoblasts of trabecular bone (tb) (D–F). bc, bone collar; f, head of
femur; pa, periarticular cartilage; pc, perichondrium. Scale bar, 200µm (A–H, J–R); 100µm (I).
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Figure 6 Analysis of the interaction of the Pe1 element with Sox proteins in vitro
(A) 32P-labelled Pe1 was incubated with 2.0µg of GST alone (lane 2) and increasing amounts (0.25, 0.5, 1.0 and 2.0µg) of purified GST–SOX9 (lanes 3–6). No protein was added to lane F (free
probe). (B) Radiolabelled Pe1 was incubated with 3µg of nuclear proteins extracted from CEC, CEF and NIH3T3 cells (lanes 2–4). The binding of chondrocyte nuclear proteins was competed with
50- and 500-fold molar excesses of Pe1, consensus Sox9 and HMG elements (lanes 6–11). No competitor was added to lane 5. (C) Supershift experiment was performed without antiserum (lane 2)
and with 1µl each of preimmune antiserum (PI) (lane 3) and antibodies specifically recognizing Sox9, L-Sox5 and Sox6 (lanes 4–6). The arrows point to the supershifted complexes.
Figure 7 Mutational analysis of Pe1 by EMSA
(A) Nucleotide sequences of the wild-type and mutant versions of Pe1. The inverted repeats (arrows) harbouring the paired Sox motifs as well as protections and hyperreactivities are indicated as
in Figure 5. Point mutations presented in bold lower case letters were introduced at nucleotides, which showed in vivo occupancy at the Sox motifs or in the spacer region. (B) Interaction of the
wild-type (lane 1) and mutant versions (lanes 2–5) of radiolabelled Pe1 with 2.0µg of purified GST–SOX9. Binding of radiolabelled Pe1 to GST–SOX9 was competed by 50- and 500-fold molar
excess of unlabelled normal and mutant Pe1 as indicated on the top (lanes 8–17). (C) EMSA was performed to compare the CEC nucleoprotein complexes formed on the wild-type and mutant Pe1
elements (lanes 1–5). Formation of CEC nucleoprotein complexes was competed with 50- and 500-fold molar excess of unlabelled Pe1 and its mutant versions as indicated on the top (lanes 8–17).
No competitor was added to lane 7. F, free probe.
the inverted nonameric Sox motifs, or the spacer region between
them (Pe1M4) (Figure 7A). These oligonucleotides were used
as probes in EMSA with purified recombinant SOX9 and CEC
nuclear proteins. Mutants Pe1M1, Pe1M2 and Pe1M3 did not
bind to GST–SOX9 (Figure 7B, lanes 1–4) and did not compete
for binding of Pe1 to either purified recombinant SOX9 or CEC
nuclear proteins (Figures 7B and 7C, lanes 6–15). In other words,
point mutations in either of the paired Sox motifs prevented the
interaction between GST–SOX9 and Pe1, indicating that both
nonameric Sox motifs within the pair were essential for reco-
gnition by SOX9. Consistent with earlier observations [35], these
results clearly demonstrate the importance of paired Sox sites
in cartilage-specific gene regulation. Mutations M1, M2 and M3
also equally interfered with the formation of CEC nucleoprotein
complexes I and II, but yielded a very slowly migrating complex
(Figure 7C, lanes 2–4). Since competition with a Sox-binding
site or wild-type Pe1 element did not diminish the latter complex
(results not shown), we concluded that the mutagenesis possibly
created a binding site for an unknown nuclear factor synthesized
in chondrocytes. However, the unknown nuclear factor did not
recognize the wild-type element. The observation that mutations
in either one of the inverted Sox motifs disrupted not only the Sox-
specific complexes II, but complex I as well suggests that the
formation of the two complexes is not completely independent.
This gives rise to two possibilities. One explanation can be that
the mutations also disrupted the overlapping binding site for a
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Figure 8 Functional analysis of Pe1 in transient expression assays
Luciferase reporter constructs harbouring the minimal or the proximal promoter region of the matrilin-1 gene (A) or promoter fragments of increasing length (B) between positions indicated are
shown on the left. Construct 4× Pe1-MpLuc carries four tandem copies of Pe1 upstream of the minimal promoter. Point mutations Pe1M1 and Pe1M4 were introduced into Pe1 of FO15Luc in
derivatives∆Pe1M1 and∆Pe1M4 . Luciferase activities of constructs are expressed in percentage of that of the FO15Luc set at 100%. Values represent the averages+− S.E.M. of 5–10 independent
transfection experiments in CEC, CEF and HDM cultures. Asterisks indicate the values shown as averages of three independent experiments.
currently unidentified factor forming complex I. The alternative,
and more likely explanation can be that binding of Sox9
homodimers to the paired sites can cause bending of the DNA, and
thereby may promote an otherwise very weak interaction between
Pe1 and the unidentified factor. Thus abolishment of Sox9-binding
to Pe1 may prevent the binding of the unidentified factor as well.
Pe1M4 was able to compete with the wild-type element for
binding to recombinant SOX9 or CEC nuclear proteins (Fig-
ures 7B and 7C, lanes 16 and 17). However, the spacer mutation
reduced the binding efficiency of Pe1M4 to GST–SOX9 (Fig-
ure 7B, lane 5). Contrary to Pe1, Pe1M4 formed only a single
complex of altered mobility with CEC nuclear proteins in repeated
experiments (Figure 7C, lane 5). This indicates that although the
spacer mutation did not abolish the interaction of Pe1 with GST–
SOX9, it modified the formation of CEC multiprotein complexes
on the element. The dramatic effect of point mutations supports
the conclusion that Pe1 can interact with Sox9 in vitro at the
nonameric palindrome and suggests the binding of an unknown
factor to the spacer region.
Functional analysis of the Pe1 element in transient
expression studies
To confirm that the highly conserved Pe1 element significantly
contributes to the transcriptional activity of the short promoter,
wild-type and mutant versions of the promoter between positions
−334 and +67 were fused to the luciferase reporter gene, and
the promoter activity was measured in transient expression assays
(Figure 8A). In agreement with the results in transgenic mice
[25], the minimal promoter between −15 and +67 (MpLuc) had
a very low activity in expressing and non-expressing cell types.
Extension of the sequence up to −334 in the 5′-direction in the
construct FO15Luc elevated the activity of the short promoter by
3.4-fold in chondrocytes. Activation was also observed in CEF and
HDM cultures, possibly due to the binding of ubiquitous factors
(Sp1, NFI, etc.) to the putative motifs of the short promoter in
transient expression assays. Introducing mutations M1 into one
of the paired Sox9 motifs of the Pe1 element by in situ mutagenesis
in Pe1M1 decreased the luciferase activity by almost 2-fold in
chondrocytes. The same mutation did not decrease but rather
slightly increased the promoter activity in CEF and HDM cultures,
thus demonstrating the tissue- and developmental stage-specific
effect of mutation in the Sox-binding sites of Pe1. Interestingly,
Pe1M4 containing mutations in the spacer region between the
intact Sox motifs decreased the short promoter activity in
derivative ∆Pe1M4 to 60% in chondrocytes, but not in CEF
and HDM cultures (Figure 8A). In agreement with the altered
complex formation with chondrocyte nuclear proteins in EMSA
(Figure 7C), this suggests that Pe1 probably interacts with another
protein in chondrocytes that is also critical for the activity of the
element. Based on the functional assays, we conclude that Pe1
is likely to contribute significantly to the short promoter activity
by binding to cartilage-specific Sox proteins through the inverted
motifs and to a currently unidentified factor in the spacer region.
When longer promoter fragments including the putative Dpe1
and Dpe2 elements were tested in transient expression assays, we
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observed 12.4- and 26.9-fold enhancement of the reporter gene
activity of constructs pCMPLuc and AC8Luc respectively in CEC
cultures (Figure 8B). In contrast, the upstream promoter elements
of pCMPLuc resulted in only 1.8- and 2.6-fold increase of the
luciferase activity in CEF and HDM cultures. This indicates that
upstream promoter elements can highly increase the tissue- and
stage-specific activity of the matrilin-1 promoter.
The Pe1 element is found within 100–200 bp upstream of the
TATA motif in various amniotes (Figure 2). To test whether this
conserved location is important for the function, four copies of
the element were placed upstream of the minimal promoter in
construct 4×Pe1-MpLuc. However, this further decreased (CEC
and HDM) or did not alter significantly (CEF) the luciferase
activity as compared with the minimal promoter construct MpLuc
(Figure 8A), suggesting that the Pe1 element cannot drive the
promoter in such a close proximity to the TATA motif or it may
work co-operatively with adjacent sequences binding to other
factors.
DISCUSSION
Organization of chondrocytes into distinct zones of the growth
plate plays an important role in the formation and longitudinal
growth of long bones. Disturbance of the zonal distribution leads
to severe developmental problems [1,3]. Identification of regu-
latory mechanisms driving the gene expression to specific zones
would be very useful. The unique feature of the matrilin-1 gene
among cartilage-specific genes is the characteristic expression
pattern restricted to distinct zones of the growth plate in vivo or
developmental stages in tissue cultures. Recent analysis of the
major regulatory regions of the chicken matrilin-1 gene in trans-
genic mice revealed that the long promoter alone or in combi-
nation with the intronic enhancer as well as the short promoter
with the intronic enhancer restricted the transgene expression
to the columnar proliferative chondroblasts and prehypertrophic
chondrocytes [25]. As all these transgenes shared the short
promoter between −338 and +67, we asked (1) whether the
proximal promoter region itself harbours cartilage-specific control
elements and (2) whether the same elements are able to exert
developmental-stage specificity to the promoter as well.
To address these questions, in the present study, we character-
ized the short promoter of the chicken matrilin-1 gene in trans-
genic mice and demonstrated cartilage-specific interaction of
transcription factors with the conserved Pe1 element containing
inverted Sox motifs using in vitro assays and in vivo footprinting.
We provided evidence that each of the 12 founder mice tested
histologically exhibited similar zonal differences in the transgene
expression in the developing cartilaginous elements of the chon-
drocranium, appendicular and axial skeleton. This implies that
the proximal promoter region indeed harbours DNA elements,
which can direct the developmental stage-specific expression of
the transgene in chondrocytes. The X-Gal staining, however,
showed a relatively low transgene activity, which was often
accompanied by weak or hardly detectable ectopic expression of
variable patterns in other tissues, indicating that the DNA elements
carried by the short promoter were alone not sufficient to drive a
high-level transgene expression, fully restricted to chondrocytes
independent of the site of integration. Our results suggest that the
tissue- and the developmental stage-specific control mechanisms
are at least partly connected to one another. Comparison of
the reporter gene activity between FO15Luc and AC8Luc and
between the NAD1 ( present study), TR70 and VAM1 transgenes
[25] revealed that distal promoter and intronic elements highly
enhanced the promoter activity and greatly increased the zonal
differences in the transgene expression. The lack of significant
differences in the NAD1 transgene expression between proximal
and distal structures supports the assumption that DNA elements,
which restricted the LacZ expression of the TR70, VAM1 and
VAM2 transgenes to distal structures [25], are also located outside
the proximal promoter region.
Results published in the present study are consistent with our
previous observations [6,23–25]. Results presented here line up
with previous reports of others [8,9,16–18] demonstrating the
essential role of Sox9, L-Sox5 and Sox6 in chondrogenesis and
cartilage-specific gene regulation. Binding of Sox9 to the en-
hancer elements of the Col2a1, Col11a2, CD-RAP and aggrecan
genes has been well documented using in vitro DNA–protein inter-
action assays [18,35–37]. However, differing from the regulatory
mechanisms reported for other cartilage protein genes, the present
study describes for the first time the significance of a proximal
promoter element recognized by cartilage-specific Sox transcrip-
tion factors in the tissue- and stage-specific transcriptional control
of the matrilin-1 gene.
Pe1 elements harbouring inverted Sox motifs were found in
similar position in the proximal promoter region of the various
amniote matrilin-1 genes (Figure 2). Although we found the
matrilin-1 gene in the fugu and zebrafish genome, we could not
identify their first exons, and thus the potential promoter regions.
The observation that, contrary to the sequence divergence in other
parts of the matrilin-1 regulatory regions in the various species,
Pe1 remained strongly conserved under evolutionary pressure be-
tween chicken and mammals implies that the element performs
a very important function in the transcriptional regulation of the
matrilin-1 gene in amniotes. Phylogenetic conservation of impor-
tant regulatory sequences has also been reported in other systems,
leading to a similar conclusion. For example, Sox2 enhancers
were functionally identified within extragenic sequence blocks
clearly conserved between chicken and mammals [38]. From the
25 conserved sequence blocks, however, only two occurred in
the fish genome as well, but similarly to our findings reported
in the present study, the conserved regulatory elements were
hidden within longer stretches of sequence similarity, when only
mammalian species were compared. Species-specific variations
in the occurrence of conserved regulatory Sox2 sequence blocks
were related to distinct spatio-temporal differences in the gene ex-
pression between vertebrate species [39,40]. These and our find-
ings support the conclusion that sequence conservations between
chicken and mammals are reliable indications of important
regulatory regions within a genetic locus.
Tissue-specific control elements have been identified in the
promoter of certain eukaryotic genes, for example between 15 and
200 bp upstream of the TATA box of liver- or osteoblast-specific
genes [41–43]. Furthermore, it has also been reported that SOX9
interacting with the partner transcription factor SF-1 recognizes
a conserved DNA element approx. 100 bp upstream of the TATA
box of mammalian anti-Mu¨llerian hormone genes [32]. Even
though inverted Sox motifs are known to play an essential role in
the function of chondrocyte-specific enhancers of the Col2a1 and
Col11a2 genes, conserved blocks similar to Pe1 could be found
neither in their proximal promoter elements nor within the 3 kb
region of the putative promoters of these genes in human, mouse
and rat by computer search using the programs DIALIGN2 and
MEME [29,30]. In accordance with this observation, the proximal
promoter region of neither the Col2a1 and Col11a1 nor the Agc
and the CDRAP genes were reported to mediate cartilage-specific
regulation [44–46]. Interestingly, consistent with its conserved
position in amniotes, the Pe1 element seems to function at a certain
distance from the TATA box. In this respect, it also clearly differs
from the cartilage-specific enhancer elements of other cartilage-
protein genes [18,35–37,44–47]. These findings imply that Pe1
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is a unique control element of the matrilin-1 gene not shared by
other cartilage protein genes.
In our experiments, GST–Sox9 formed only a single complex
with Pe1. Even though Sox9 is not capable of forming homo-
dimers in solution [18,48,49], consistent with observations from
other laboratories [35,50], we found that it could bind only to
intact inverted pairs of Sox motifs (Figure 7B), thus supporting
the conclusion that Sox9 dimerization might have occurred upon
DNA binding. As opposed to this, Sox9 was reported to bind as a
monomer to cis elements involved in sex determination [50].
Transient expression studies confirmed that Pe1 significantly
contributed to the moderate activity of the short promoter in
chondrocytes. Based on the data, we hypothesize that the element
does not drive the high cartilage-specific expression of the pro-
moter as an enhancer, but may rather act by modulating the
promoter activity and mediating the effect of distal promoter and
intronic enhancer elements. We also hypothesize that distal pro-
moter and intronic elements may also function by forming multi-
protein complexes by interacting with Pe1. Although Pe1 can bind
to Sox9, L-Sox5 and Sox6 in vitro, it may show a preference for
Sox9 in vivo, as the inverted Sox motifs carried by Pe1 are more
similar to the preferred binding sites of Sox9, than to those of
L-Sox5/Sox6. On the other hand, the conserved Dpe1 element
carries motifs more similar to the preferred binding sites of L-
Sox5/Sox6. Binding of Dpe1 to these factors and the interaction
with nucleoprotein complexes formed on Pe1 may be necessary
for the high tissue- and developmental stage-specific activity of
the 2011 bp promoter in AC8Luc and TR70 transgenic mice [25].
Thus the Sox9 and L-Sox5/Sox6-binding sites may be separated
over a large distance in the regulatory region of the matrilin-1
gene. The importance of L-Sox5/Sox6 binding is supported by the
observation that Sox9 alone is not sufficient for the activation of
the matrilin-1 gene in the absence of Sox5 and Sox6 proteins [17].
By bending the DNA, HMG box proteins are known to promote
the binding of other transcription factors to the DNA. Lining up
with these observations, our results suggest that, in addition to
Sox proteins, other transcription factors may also be involved
in the activity of the short matrilin-1 promoter. Sox9 is known
to interact with a number of partner factors, including SF-1 and
LcMaf [11,32,51]. One explanation for the conserved position
of the Pe1 element can be that it may function by bending the
DNA and promoting the interaction between the components of
the polymerase II transcription machinery and ubiquitous factors
bound to the proximal promoter elements. This assumption is sup-
ported by the observation that the short promoter includes several
putative binding sites for ubiquitous transcription factors, such
as Sp1 and NFI, and based on our genomic footprinting studies,
these motifs were also occupied by transcription factors bound
in vivo in chondrocytes (Figure 5; and results not shown).
Furthermore, Sox9 may interact with different partner factors
during subsequent steps of chondrogenesis, thereby contributing
to the developmental stage-specific activity of the matrilin-1 gene.
However, future studies will be needed for mapping the putative
cofactor-binding sites and identifying the interacting Sox partner
factors on the Pe1 element.
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